Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 13/20 | 0.53 |
| ▸ | HSP90B1 | P14625 | 3/20 | 0.52 |
| ▸ | ADORA1 | P30542 | 8/20 | 0.51 |
| ▸ | TMIGD3 | P0DMS9 | 3/20 | 0.50 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.46 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.44 |
| ▸ | AHCY | P23526 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25566672 | 0.89 | AHCY (0.56) | ADORA3HSP90B1ADORA1ADORA2AAHCY | |
| SCHEMBL25566627 | 0.86 | P2RY1 (0.51) | ADORA3HSP90B1ADORA1ADORA2AP2RY1 | |
| SCHEMBL25566681 | 0.84 | ADORA3 (0.71) | ADORA3ADORA1TMIGD3ADORA2A | |
| SCHEMBL19503864 | 0.78 | ADORA3 (0.69) | ADORA3HSP90B1ADORA1TMIGD3ADORA2A | |
| SCHEMBL21939656 | 0.77 | ADORA3 (0.61) | ADORA3ADORA1TMIGD3ADORA2A | |
| SCHEMBL21940221 | 0.77 | ADORA3 (0.75) | ADORA3ADORA1TMIGD3ADORA2A | |
| SCHEMBL17243941 | 0.77 | ADORA3 (0.60) | ADORA3HSP90B1ADORA1TMIGD3ADORA2A | |
| SCHEMBL21939669 | 0.74 | ADORA3 (0.71) | ADORA3 | |
| SCHEMBL25566752 | 0.73 | ADORA1 (0.47) | ADORA3HSP90B1ADORA1TMIGD3ADORA2A | |
| SCHEMBL25566673 | 0.72 | ADORA3 (0.47) | ADORA3HSP90B1ADORA1TMIGD3ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023091791-A1 | METHODS OF TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS | ASTROCYTE PHARMACEUTICALS, INC. (US) | 2023-05-25 | — | — | WO | disclosed |